Insider filing · NEO
Alicia C Olivo
EVP, GC & Business Development
profile →
NeoGenomics, Inc.
NEO · Healthcare · 8 filings in 24 months
ticker →
Alicia C Olivo sold $251K of NeoGenomics (NEO)
Executed Nov 25 2025, disclosed Nov 28 2025, 3 days later.
Value, as filed
$251K
20,916 sh × $12.00
Executed
Nov 25 2025
the trade date, as filed
Disclosed
Nov 28 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AOAlicia C Olivo (EVP, GC & Business Development) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in NeoGenomics, Inc. (NEO). The largest single filing was $251K of NEO (20,916 sh × $12.00, as filed), executed Nov 25 2025.
The name
NEOHealthcare · NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→